论文信息 - Dasatinib in imatinib‐resistant or imatinib‐intolerant chronic myeloid leukemia in blast phase after 2 years of follow‐up in a phase 3 study - 字舞流文

Dasatinib in imatinib‐resistant or imatinib‐intolerant chronic myeloid leukemia in blast phase after 2 years of follow‐up in a phase 3 study

H. Dombret | J. Cortes | R. Paquette | G. Saglio | P. Erben | A. Hochhaus | T. Masszi | F. Maloisel | M. Bradley-Garelik | R. Pasquini | Y. Goh | Chao Zhu | M. Brigid Bradley‐Garelik | M. B. Bradley-Garelik